Holen Sie sich die Stockscreener-App
6.9999
0.58%
0.0499
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TLRY?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$6.95
Offen:
$7
24-Stunden-Volumen:
658.69K
Relative Volume:
0.08
Marktkapitalisierung:
$814.37M
Einnahmen:
$837.32M
Nettoeinkommen (Verlust:
$-2.10B
KGV:
-0.3165
EPS:
-22.1159
Netto-Cashflow:
$-67.35M
1W Leistung:
-3.05%
1M Leistung:
-6.92%
6M Leistung:
-37.59%
1J Leistung:
+18.66%
1-Tages-Spanne:
$6.97
$7.14
1-Wochen-Bereich:
$6.83
$7.50
52-Wochen-Spanne:
$3.507
$23.20
Tilray Brands Inc Stock (TLRY) Company Profile
Firmenname
Tilray Brands Inc
Sektor
Telefon
519.322.8800
Adresse
655 MADISON AVENUE, NEW YORK
Compare TLRY vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
6.9899 | 809.72M | 837.32M | -2.10B | -67.35M | -22.12 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 56.14B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.38 | 48.74B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.09 | 44.85B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.82 | 34.12B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
535.95 | 23.35B | 3.13B | 1.27B | 1.12B | 26.39 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-27 | Eingeleitet | Canaccord Genuity | Hold |
| 2024-04-05 | Bestätigt | Alliance Global Partners | Neutral |
| 2022-11-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-07-29 | Herabstufung | The Benchmark Company | Hold → Sell |
| 2022-03-04 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-11-18 | Eingeleitet | Barclays | Underweight |
| 2021-11-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-06-11 | Herabstufung | CIBC | Sector Outperform → Neutral |
| 2021-06-03 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-05-11 | Fortgesetzt | Cowen | Outperform |
| 2021-05-07 | Fortgesetzt | Jefferies | Buy |
| 2021-05-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-04-28 | Fortgesetzt | BofA Securities | Buy |
| 2021-02-18 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-02-18 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-11-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-11-11 | Herabstufung | Stifel | Hold → Sell |
| 2020-10-01 | Bestätigt | MKM Partners | Neutral |
| 2020-09-21 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-05-12 | Bestätigt | The Benchmark Company | Buy |
| 2020-04-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-04-09 | Herabstufung | Consumer Edge Research | Overweight → Equal Weight |
| 2020-02-24 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-01-13 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-11-13 | Bestätigt | The Benchmark Company | Buy |
| 2019-11-05 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2019-10-22 | Bestätigt | Piper Jaffray | Overweight |
| 2019-09-20 | Eingeleitet | MKM Partners | Neutral |
| 2019-08-14 | Bestätigt | The Benchmark Company | Buy |
| 2019-07-17 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2019-06-28 | Eingeleitet | Consumer Edge Research | Overweight |
| 2019-06-06 | Eingeleitet | Stifel | Hold |
| 2019-06-05 | Eingeleitet | Oppenheimer | Perform |
| 2019-05-15 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2019-05-13 | Eingeleitet | Alliance Global Partners | Neutral |
Alle ansehen
Tilray Brands Inc Aktie (TLRY) Neueste Nachrichten
Tilray Brands (TSE:TLRY) Trading Down 3.3%Should You Sell? - MarketBeat
Tilray Brands, Inc. (TLRY) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Trading Down 3.7%Here's Why - MarketBeat
(TLRY) Risk-Controlled Trading Report (TLRY:CA) - Stock Traders Daily
Strategic Craft Beer Acquisitions - Trend Hunter
Promising Cannabis Stocks To Follow TodayMarch 12th - MarketBeat
Tilray Expands German Healthcare Push With Strategic Pharma Deal - Benzinga
Should Cresco Stock Be in Your Portfolio Post Q4 Earnings? - The Globe and Mail
Tilray Brief: Tilray Medical, CC Pharma, and 14U Pharma In Strategic Alliance with "gesund leben" Cooperation and Alliance Healthcare Deutschland - marketscreener.com
Tilray Medical, CC Pharma, and 14U Pharma Announce Strategic Alliance with 'gesund leben” Cooperation and Alliance Healthcare Deutschland to Accelerate Market Expansion and Strengthen Pharmacy Access Across Germany - The Manila Times
Tilray Brands acquires BrewDog Australia - theshout.com.au
Tilray’s $33M BrewDog Acquisition Could Unlock A $500M Beverage Empire! - Smartkarma
BrewDog Australia acquired by Tilray Brands - Beer & Brewer
Promising Cannabis Stocks To Follow NowMarch 11th - MarketBeat
Tilray (TLRY) Launches New Light Beer to Refresh Brand Offerings - GuruFocus
Lighter. Cheaper. Funner. Pub Light Is Here. - markets.businessinsider.com
What's Going On With Tilray Brands Stock Wednesday?Tilray Brands (NASDAQ:TLRY) - Benzinga
Tilray Brands Launches Pub Light: A New Easy-Drinking American-Style Light Lager - Quiver Quantitative
Cresset Asset Management LLC Acquires 210,267 Shares of Tilray Brands, Inc. $TLRY - MarketBeat
LAST ORDERS - marketscreener.com
Tilray Brands, Inc. (NASDAQ:TLRY) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Tilray’s BrewDog Australia Deal Expands Asia Pacific Reach Amid Weak Shares - simplywall.st
Tilray Brands (NASDAQ:TLRY) Shares Down 2%Here's What Happened - MarketBeat
Promising Cannabis Stocks Worth WatchingMarch 10th - MarketBeat
Tilray’s BrewDog Australia Deal Expands Beverage Reach And Investor Debate - Yahoo Finance
Tilray Brands expects to generate $1.2 billion in revenue next year, and it's not the way investors might have expected - MSN
Tilray Brands (NASDAQ:TLRY) Trading Up 1.9%Time to Buy? - MarketBeat
Tilray Brands (TLRY) going strong amid diversification into beverages and spring products launch - MSN
Promising Cannabis Stocks To Add to Your WatchlistMarch 9th - MarketBeat
Tilray Brands Acquires BrewDog Australia - National Today
Tilray's Going To Be Great, But For Now It's A Hold (NASDAQ:TLRY) - Seeking Alpha
What's Going On With Tilray Brands Stock Monday?Tilray Brands (NASDAQ:TLRY) - Benzinga
Tilray Brands Acquires BrewDog’s Australian Brewery and 5 Pubs With Eye to Expand Sales of Key Brands - Brewbound
Tilray Brands Expects to Generate $1.2 Billion in Revenue Next Year, and It's Not the Way Investors Might Have Expected - The Globe and Mail
Tilray (TLRY) Expands Global Reach with BrewDog Australia Acquis - GuruFocus
Tilray Brands, Inc. - Baystreet.ca
Stocks in play: Tilray Brands, Inc. - Barchart.com
Tilray Brands expands global footprint; closes acquisition of BrewDog Brewing Australia - MSN
Tilray Brands acquires BrewDog’s Australia assets - Yahoo Finance
Tilray Acquires BrewDog Australia - The Crafty Pint
Tilray (TLRY) Expands Presence in Australian Craft Beer Market - GuruFocus
Tilray Brands Acquires BrewDog Australia, Establishing Strategic Base to Accelerate Global Beverage and Consumer Products Growth Across the Asia-Pacific Region - marketscreener.com
Tilray Brands Acquires BrewDog Australia, Establishing… - aapnews.aap.com.au
Tilray Brands Expands Beer And Cannabis Footprint With Carlsberg Deal - Yahoo Finance
Cannabis Stocks To Watch TodayMarch 8th - MarketBeat
Tilray Brands, Inc. (TLRY) Acquires BrewDog - Finviz
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Forget Tilray: This Cash‑Flow Monster Can Outlast Every Cannabis Hype Cycle - Nasdaq
Forget Tilray: This Cash‑Flow Monster Can Outlast Every Cannabis Hype Cycle - The Motley Fool
Tilray Brands (NASDAQ:TLRY) Lowered to Sell Rating by Wall Street Zen - MarketBeat
TLRY Stock Quote Price and Forecast - CNN
Finanzdaten der Tilray Brands Inc-Aktie (TLRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tilray Brands Inc-Aktie (TLRY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SIMON IRWIN D | President and CEO |
Jul 31 '25 |
Option Exercise |
0.58 |
706,216 |
409,605 |
5,200,788 |
| Merton Carl A | Chief Financial Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
970,279 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
742,069 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Buy |
0.58 |
6,000 |
3,496 |
698,287 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
874,564 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 30 '25 |
Option Exercise |
0.61 |
261,194 |
159,328 |
919,069 |
| Herhalt Johann Michael | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
239,930 |
| Looney Thomas P. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
354,416 |
| Hopkinson David G. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
335,563 |
| Clanachan David F | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
236,880 |
0.81%
0.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):